BIOMARIN PHAR. DL-,001/ US09061G1013 /
| 15/11/2024 08:09:16 | Chg. -1.1800 | Volume | Bid21:59:59 | Ask21:59:59 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 61.6000EUR | -1.88% | 0 Turnover: 0.0000 |
-Bid Size: - | -Ask Size: - | 11.48 bill.EUR | - | - |
Assets
| 2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 948.6820 | 1,010.8680 | 1,032.4710 | 1,035.4610 | 1,073.3660 | ||||||
| Intangible Assets | 491.8080 | 456.5800 | 417.2710 | 388.6520 | 338.5690 | ||||||
| Long-Term Investments | 235.8640 | 411.9780 | 285.4730 | 507.7930 | 333.8350 | ||||||
| Fixed Assets | 2,370.9130 | 2,747.8960 | 3,505.8010 | 3,728.9400 | 3,623.6170 | ||||||
| Inventories | 530.8710 | 680.2750 | 698.5480 | 776.6690 | 894.0830 | ||||||
| Accounts Receivable | 342.6330 | 377.4040 | 448.3510 | 373.3990 | 461.3160 | ||||||
| Cash and Cash Equivalents | 493.9820 | 437.4460 | 649.1580 | 587.2760 | 724.5310 | ||||||
| Current Assets | 2,056.2150 | 1,942.1430 | 2,342.2190 | 2,274.3850 | 2,751.4570 | ||||||
| Total Assets | 4,427.1280 | 4,690.0390 | 5,848.0200 | 6,003.3250 | 6,375.0740 | ||||||
Liabilities
| 2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | - | - | - | - | - | ||||||
| Long-term debt | 830.4170 | 486.2380 | 1,075.1450 | 1,079.0770 | 1,083.0190 | ||||||
| Liabilities to Banks | 0.0000 | 0.0000 | 0.0000 | 0.0000 | - | ||||||
| Provisions | - | - | - | - | - | ||||||
| Liabilities | 1,459.1880 | 1,567.6580 | 1,742.0180 | 1,732.5850 | 1,771.9180 | ||||||
| Share Capital | .1780 | .1800 | .1820 | .1840 | .1860 | ||||||
| Total Equity | 2,967.9400 | 3,122.3810 | 4,106.0020 | 4,270.7400 | 4,603.1560 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 4,427.1280 | 4,690.0390 | 5,848.0200 | 6,003.3250 | 6,375.0740 | ||||||
Income Statement
| 2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 1,491.2120 | 1,704.0480 | 1,860.4550 | 1,846.2750 | 2,096.0390 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | -123.5240 | -100.4570 | -36.7650 | -82.3410 | 149.5620 | ||||||
| Interest Income | -20.8330 | -.7120 | -12.6990 | -4.8550 | 2.0640 | ||||||
| Income Before Taxes | -142.7050 | -94.8110 | -42.3220 | -75.3500 | 149.5760 | ||||||
| Income Taxes | -65.4940 | -70.9630 | -901.4220 | -11.2700 | 8.0150 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | -77.2110 | -23.8480 | 859.1000 | -64.0800 | 141.5610 | ||||||
Per Share
Cash Flow
| 2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 20.2080 | 48.2620 | 85.3650 | 304.5360 | 175.9020 | ||||||
| Cash Flow from Investing Activities | 264.3510 | -31.0260 | -53.6210 | -366.3130 | -20.0290 | ||||||
| Cash Flow from Financing | -388.0070 | -74.6740 | 181.1180 | -.0480 | -18.6500 | ||||||
| Decrease / Increase in Cash | -104.0460 | -56.5360 | 211.7120 | -61.8820 | 137.2550 | ||||||
| Employees | 2,849 | 3,001 | 3,059 | 3,045 | - | ||||||
